510(k) K220911

Elecsys CMV IgG by Roche Diagnostics — Product Code LFZ

K220911 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys CMV IgG". The FDA issued a decision of Substantially Equivalent on October 12, 2022. The device falls under product code LFZ (Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus), a Class II device regulated under 21 CFR 866.3175. Roche Diagnostics has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 12, 2022
Date Received
March 29, 2022
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Enzyme Linked Immunoabsorbent Assay, Cytomegalovirus
Device Class
Class II
Regulation Number
866.3175
Review Panel
MI
Submission Type